MS Speaks

Multiple Sclerosis => TREATMENTS => TYSABRI (natalizumab) => Topic started by: agate on March 12, 2018, 09:38:38 pm

Title: Relationship between Tysabri-related PML and the JC virus
Post by: agate on March 12, 2018, 09:38:38 pm

JAMA Neurology (March 12) contains two articles investigating the relationship between Tysabri-related PML and the JC virus:


"Association of progressive multifocal leukoencephalopathy lesion volume with JC virus polymerase chain reaction results in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis":


https://jamanetwork.com/journals/jamaneurology/article-abstract/2674280?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaneurology&utm_content=olf&utm_term=031218&redirect=true


"Progressive multifocal leucoencephalopathy lesions and JC virus: The limits and value of imaging":


https://jamanetwork.com/journals/jamaneurology/fullarticle/2674273?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaneurology&utm_content=olf&utm_term=031218
Title: Article on connection between PML and JC virus one of most talked about articles of 2018
Post by: agate on December 30, 2018, 03:59:34 pm
The article cited in the previous post has been chosen as one of the 10 most talked about articles in JAMA Neurology in 2018. The link below gives the entire article:


https://jamanetwork.com/journals/jamaneurology/fullarticle/2674280?guestAccessKey=bab12c9a-021f-493d-bddc-27f5a7166a79&utm_source=silverchair&utm_campaign=altmetric&utm_content=2018_year-end&cmp=1&utm_medium=email